BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 11000405)

  • 1. An essential octamer motif in the mb-1 (Igalpha) promoter.
    Malone CS; Patrone L; Wall R
    Mol Immunol; 2000 Apr; 37(6):321-8. PubMed ID: 11000405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bob1 (OCA-B/OBF-1) differential transactivation of the B cell-specific B29 (Ig beta) and mb-1 (Ig alpha) promoters.
    Malone CS; Wall R
    J Immunol; 2002 Apr; 168(7):3369-75. PubMed ID: 11907094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An upstream Oct-1- and Oct-2-binding silencer governs B29 (Ig beta) gene expression.
    Malone CS; Patrone L; Buchanan KL; Webb CF; Wall R
    J Immunol; 2000 Mar; 164(5):2550-6. PubMed ID: 10679093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell type- and stage-specific expression of the CD20/B1 antigen correlates with the activity of a diverged octamer DNA motif present in its promoter.
    Thévenin C; Lucas BP; Kozlow EJ; Kehrl JH
    J Biol Chem; 1993 Mar; 268(8):5949-56. PubMed ID: 7680653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early B-cell factor, E2A, and Pax-5 cooperate to activate the early B cell-specific mb-1 promoter.
    Sigvardsson M; Clark DR; Fitzsimmons D; Doyle M; Akerblad P; Breslin T; Bilke S; Li R; Yeamans C; Zhang G; Hagman J
    Mol Cell Biol; 2002 Dec; 22(24):8539-51. PubMed ID: 12446773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Octamer independent activation of transcription from the kappa immunoglobulin germline promoter.
    Prabhu A; O'Brien DP; Weisner GL; Fulton R; Van Ness B
    Nucleic Acids Res; 1996 Dec; 24(23):4805-11. PubMed ID: 8972869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The promoter and 5' flanking sequences controlling human B29 gene expression.
    Thompson AA; Wood WJ; Gilly MJ; Damore MA; Omori SA; Wall R
    Blood; 1996 Jan; 87(2):666-73. PubMed ID: 8555489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencer elements controlling the B29 (Igbeta) promoter are neither promoter- nor cell-type-specific.
    Malone CS; Omori SA; Wall R
    Proc Natl Acad Sci U S A; 1997 Nov; 94(23):12314-9. PubMed ID: 9356446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A B-cell coactivator of octamer-binding transcription factors.
    Gstaiger M; Knoepfel L; Georgiev O; Schaffner W; Hovens CM
    Nature; 1995 Jan; 373(6512):360-2. PubMed ID: 7779176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple motifs regulate the B-cell-specific promoter of the B29 gene.
    Omori SA; Wall R
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11723-7. PubMed ID: 8265616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter.
    Fitzsimmons D; Hodsdon W; Wheat W; Maira SM; Wasylyk B; Hagman J
    Genes Dev; 1996 Sep; 10(17):2198-211. PubMed ID: 8804314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oct-2 regulates CD36 gene expression via a consensus octamer, which excludes the co-activator OBF-1.
    Shore P; Dietrich W; Corcoran LM
    Nucleic Acids Res; 2002 Apr; 30(8):1767-73. PubMed ID: 11937630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors.
    Luo Y; Fujii H; Gerster T; Roeder RG
    Cell; 1992 Oct; 71(2):231-41. PubMed ID: 1423591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins.
    Schreiber E; Harshman K; Kemler I; Malipiero U; Schaffner W; Fontana A
    Nucleic Acids Res; 1990 Sep; 18(18):5495-503. PubMed ID: 2216722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins.
    Strubin M; Newell JW; Matthias P
    Cell; 1995 Feb; 80(3):497-506. PubMed ID: 7859290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octamer binding factors and their coactivator can activate the murine PU.1 (spi-1) promoter.
    Chen H; Zhang P; Radomska HS; Hetherington CJ; Zhang DE; Tenen DG
    J Biol Chem; 1996 Jun; 271(26):15743-52. PubMed ID: 8663022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1.
    Schubart DB; Sauter P; Massa S; Friedl EM; Schwarzenbach H; Matthias P
    Nucleic Acids Res; 1996 May; 24(10):1913-20. PubMed ID: 8657574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an octamer-1 transcription factor binding site in the promoter of the mouse mu-opioid receptor gene.
    Liang Y; Carr LG
    J Neurochem; 1996 Oct; 67(4):1352-9. PubMed ID: 8858915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The B29 (immunoglobulin beta-chain) gene is a genetic target for early B-cell factor.
    Akerblad P; Rosberg M; Leanderson T; Sigvardsson M
    Mol Cell Biol; 1999 Jan; 19(1):392-401. PubMed ID: 9858563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oct proteins are qualitative rather than quantitative regulators of kappa transcription.
    Liberg D; Sigvardsson M; Leanderson T
    Mol Immunol; 1997 Oct; 34(14):979-86. PubMed ID: 9488048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.